Cranial and spinal oligodendrogliomatosis: a case report and review of the literature

详细信息    查看全文

• 作者：Siang Liao Lee (1) (3)
  Albert Wong (1) (3)
  James A. Stadler III (1) (3)
  Jamal McClendon Jr. (1) (3)
  Timothy R. Smith (1) (3)
  Nitin R. Wadhwani (2)
  Tadanori Tomita (1) (3)
  
  1. Division of Neurosurgery ; Ann & Robert H. Lurie Children鈥檚 Hospital of Chicago ; 225 E. Chicago Ave. ; Chicago ; IL ; 60611 ; USA
  3. Department of Neurosurgery ; Feinberg School of Medicine ; Northwestern University ; 303 E Chicago Ave ; Chicago ; IL ; 60611 ; USA
  2. Department of Pathology ; Ann & Robert H. Lurie Children鈥檚 Hospital of Chicago ; 225 E. Chicago Ave. ; Chicago ; IL ; 60611 ; USA
  
• 关键词：Oligodendrogliomatosis ; Chemotherapy ; Radiation ; Temozolomide ; Radiation ; induced cavernomas ; 1p19q deletion ; Procarbazine ; Lomustine ; Vincristine
• 刊名：Child's Nervous System
• 出版年：2015
• 出版时间：January 2015
• 年：2015
• 卷：31
• 期：1
• 页码：147-153
• 全文大小：4,827 KB
• 参考文献：1. Langley PC, Coons SJ (1997) Peripheral vascular disorders. A pharmacoeconomic and quality-of-life review. PharmacoEconomics 11(3):225鈥?36 3-199711030-00004" target="_blank" title="It opens in new window">CrossRef
  2. Mathews MS, Pare LS, Kuo JV, Kim RC (2009) Primary leptomeningeal oligodendrogliomatosis. J Neuro-Oncol 94(2):275鈥?78. doi:10.1007/s11060-009-9821-8 CrossRef
  3. Armao DM, Stone J, Castillo M, Mitchell KM, Bouldin TW, Suzuki K (2000) Diffuse leptomeningeal oligodendrogliomatosis: radiologic/pathologic correlation. AJNR Am J neuroradiol 21(6):1122鈥?126
  4. Best PV (1963) Intracranial oligodendrogliomatosis. J Neurol Neurosurg Psychiatry 26:249鈥?56 36/jnnp.26.3.249" target="_blank" title="It opens in new window">CrossRef
  5. Ozkul A, Meteoglu I, Tataroglu C, Akyol A (2007) Primary diffuse leptomeningeal oligodendrogliomatosis causing sudden death. J Neuro-Oncol 81(1):75鈥?9. doi:10.1007/s11060-006-9208-z CrossRef
  6. Pitt MA, Jones AW, Reeve RS, Cowie RA (1992) Oligodendroglioma of the fourth ventricle with intracranial and spinal oligodendrogliomatosis: a case report. Br J Neurosurg 6(4):371鈥?74 3109/02688699209023798" target="_blank" title="It opens in new window">CrossRef
  7. Reynolds RM, Boswell E, Hulette CM, Cummings TJ, Haglund MM, Boswell E, Hulette CM, Cumm Ings TJ, Haglund MM (2011) Sudden death from diffuse leptomeningeal oligodendrogliomatosis. J Neurosurg Spine 15(6):625鈥?29. doi:10.3171/2011.7.SPINE10728 3171/2011.7.SPINE10728" target="_blank" title="It opens in new window">CrossRef
  8. Gardiman MP, Fassan M, Orvieto E, D'Avella D, Denaro L, Calderone M, Severino M, Scarsello G, Viscardi E, Perilongo G (2010) Diffuse leptomeningeal glioneuronal tumors: a new entity? Brain Pathol 20(2):361鈥?66. doi:10.1111/j.1750-3639.2009.00285.x 3639.2009.00285.x" target="_blank" title="It opens in new window">CrossRef
  9. Guppy KH, Akins PT, Moes GS, Prados MD (2009) Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis. J Neurosurg Spine 10(6):557鈥?63. doi:10.3171/2009.2.SPINE08853 3171/2009.2.SPINE08853" target="_blank" title="It opens in new window">CrossRef
  10. Stodberg T, Deniz Y, Esteitie N, Jacobsson B, Mousavi-Jazi M, Dahl H, Zweygberg Wirgart B, Grillner L, Linde A (2002) A case of diffuse leptomeningeal oligodendrogliomatosis associated with HHV-6 variant A. Neuropediatrics 33(5):266鈥?70. doi:10.1055/s-2002-36739 36739" target="_blank" title="It opens in new window">CrossRef
  11. Gilmer-Hill HS, Ellis WG, Imbesi SG, Boggan JE (2000) Spinal oligodendroglioma with gliomatosis in a child. Case Rep J Neurosurg 92(1 Suppl):109鈥?13
  12. Ng HK, Poon WS (1999) Diffuse leptomeningeal gliomatosis with oligodendroglioma. Pathology 31(1):59鈥?3 3130299105584" target="_blank" title="It opens in new window">CrossRef
  13. Korein J, Feigin I, Shapiro MF (1957) Oligodendrogliomatosis with intracranial hypertension. Neurology 7(8):589鈥?94 CrossRef
  14. Lassman AB, Iwamoto FM, Cloughesy TF, Aldape KD, Rivera AL, Eichler AF, Louis DN, Paleologos NA, Fisher BJ, Ashby LS, Cairncross JG, Roldan GB, Wen PY, Ligon KL, Schiff D, Robins HI, Rocque BG, Chamberlain MC, Mason WP, Weaver SA, Green RM, Kamar FG, Abrey LE, DeAngelis LM, Jhanwar SC, Rosenblum MK, Panageas KS (2011) International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro-Oncology 13(6):649鈥?59. doi:10.1093/neuonc/nor040 3/neuonc/nor040" target="_blank" title="It opens in new window">CrossRef
  15. Cairncross G, Wang M, Shaw E, Jenkins R, Brachman D, Buckner J, Fink K, Souhami L, Laperriere N, Curran W, Mehta M (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol Off J Am Soc Clin Oncol 31(3):337鈥?43. doi:10.1200/JCO.2012.43.2674 3.2674" target="_blank" title="It opens in new window">CrossRef
  16. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90(19):1473鈥?479 3/jnci/90.19.1473" target="_blank" title="It opens in new window">CrossRef
  17. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18(3):636鈥?45
  18. McNamara MG, Sahebjam S, Mason WP (2013) Anaplastic oligodendroglioma: advances and treatment options. Curr Treat Options Neurol 15(3):289鈥?01. doi:10.1007/s11940-013-0218-9 3-0218-9" target="_blank" title="It opens in new window">CrossRef
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Neurosurgery
  Neurosciences
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1433-0350

文摘

Introduction Oligodendrogliomatosis is a rarely reported entity in literature associated with poor prognosis in terms of length and quality of life. In this paper, we describe oligodendrogliomatosis in a 15-year-old male who initially presented with altered mental status due to diabetic ketoacidosis. Clinical presentation He was refractory to temozolomide initially but demonstrated disease regression with radiotherapy (XRT). More recently, he has had disease recurrence, which was stabilized with temozolomide therapy for a period of time. Conclusion Contrary to most reports in literature, our patient has had excellent quality of life since his initial diagnosis and continues to carry good prognosis. In addition to oligodendrogliomatosis, our patient also developed multiple intracranial cavernomas secondary to radiation therapy, which have remained stable and asymptomatic.